Olaparib treatment in patients (pts) with platinum-sensitive relapsed (PSR) ovarian cancer (OC) by BRCA mutation (BRCAm) and homologous recombination deficiency (HRD) status: Phase II LIGHT study Meeting Abstract
| Authors: | Cadoo, K. A.; Simpkins, F.; Mathews, C. A.; Kabil, N.; Bennett, J.; Aghajanian, C. |
| Abstract Title: | Olaparib treatment in patients (pts) with platinum-sensitive relapsed (PSR) ovarian cancer (OC) by BRCA mutation (BRCAm) and homologous recombination deficiency (HRD) status: Phase II LIGHT study |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Start Page: | 332s |
| Language: | English |
| ACCESSION: | WOS:000560368302441 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.6013 |
| Notes: | Meeting Abstract: 6013 -- Source: Wos |
